A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated prognostic score b...
Main Authors: | Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, Naoya Kanogawa, Tenyu Motoyama, Eiichiro Suzuki, Akinobu Tawada, Ryosaku Azemoto, Masami Shinozaki, Masaharu Yoshikawa, Osamu Yokosuka |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4412579?pdf=render |
Similar Items
-
Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.
by: Sadahisa Ogasawara, et al.
Published: (2016-01-01) -
Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.
by: Toru Wakamatsu, et al.
Published: (2017-01-01) -
Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma.
by: Sadahisa Ogasawara, et al.
Published: (2016-01-01) -
Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer
by: Akinobu Tawada, et al.
Published: (2014-03-01) -
Cholangiocarcinoma Derived from Remnant Intrapancreatic Bile Duct Arising 32 Years after Congenital Choledochal Cyst Excision: A Case Report
by: Kentaro Ishikawa, et al.
Published: (2015-06-01)